Table 4 Agreement of self- and clinician-collected samples by HPV assay
| Â | Â | Clinician-collected samples | Â | Â | Â | Â | ||
|---|---|---|---|---|---|---|---|---|
| Â | Â | HPV positive | HPV negative | Total | Cohens kappa | Agreement | ||
| Â | Self-collected | n (%) | n (%) | n (%) | Îşb | (95% CI) | % | (95% CI) |
14-type | HPV positivea | 51 (10.1) | 64 (12.7) | 115 (22.8) | Â | Â | Â | Â |
DNA | HPV negative | 46 (9.1) | 344 (68.1) | 390 (77.2) |  |  | 78.2c | (74.6–81.8) |
assay | Total | 97 (19.2) | 408 (80.8) | 505 (100.0) | 0.34e | (0.25–0.44) | 31.7d | (24.7–39.5) |
7-type | HPV positiveb | 15 (3.0) | 21 (4.2) | 36 (7.1) | Â | Â | Â | Â |
mRNA | HPV negative | 17 (3.4) | 452 (89.5) | 469 (92.9) | 0.40e | (0.25–0.56) | 92.5c | (90.2–94.8) |
assay | Total | 32 (6.3) | 473 (93.7) | 505 (100.0) | 0.30f | (0.12–0.48) | 28.3d | (17.2–42.3) |